Cat No.C-037
OrganismHuman
TissueCardiac
DiseaseNormal
Growth PropertiesEmbedded 3D Culture
Biosafety Level1
Growth conditions37℃, 95% Air, 5% CO2
Size/Quantity1
Product formatFrozen
Shipping InfoDry Ice
Storage conditionsLiquid Nitrogen

View Product Image

Description

Human iPSC-derived cardiac organoids are three-dimensional, self-organizing microtissues generated from human dermal fibroblast–derived iPSCs reprogrammed with OCT4, SOX2, KLF4, and c-MYC using a non-integrating Sendai virus system. These organoids display chamber-like morphology, spontaneous contractility, and express key cardiac markers such as cTnT, α-actinin, NKX2.5, and connexin-43, while maintaining normal karyotype stability. Quality control includes rigorous testing for mycoplasma, bacteria, fungi/yeast, and verification of genetic integrity and functional performance. With integrated populations of cardiomyocytes, fibroblasts, and endothelial cells, they provide a physiologically relevant platform for modeling cardiomyopathies, arrhythmias, and ischemic injury, as well as for drug cardiotoxicity screening, electrophysiological studies, and regenerative medicine applications.

Specifications & Applications

Growth Properties

Embedded 3D Culture

Quality Control

All test negative for mycoplasma, bacteria, yeast, and fungi.

Application

For research use only. iPSC-derived organoids are used in various research fields, including disease modeling, drug discovery, gene therapy evaluation, and personalized medicine. They can replicate diverse disease states, providing reliable platforms for studying cancer, cardiovascular conditions, and more. Additionally, organoids are valuable for drug efficacy and safety testing, tissue regeneration studies, and exploring host-microbe interactions, advancing innovation in biomedical research.

Tags

Inquiring Human iPSC-derived Cardiac Organoid

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.

Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.

Let's build the future of translational research together.

Let's Talk Now

Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.

Let's build the future of translational research together.

Let's Talk Now